SAUDI EXPATRIATES

Pfizer to supply one million doses of the vaccine by the end of February 2021 to the Kingdom of Saudi Arabia. The Ministry of Health said that the Kingdom will approve other vaccines after undergoing the tests.

The Saudi Food and Drug Authority (SFDA) had issued its approval to register the Pfizer-BioNTech Coronavirus Vaccine in the Kingdom. Aspects of the review included evaluating vaccine efficacy and safety data illustrated in clinical trials and studies. Related : Corona vaccine will be provided in all regions of Saudi Arabia within 3 weeks

- As well as verifying the quality of the vaccine by reviewing scientific data that shows the quality of manufacturing and the stability of the product, in addition to verifying the manufacturing stages and the manufacturer's commitment to applying the principles of good pharmaceutical manufacturing, as per the international standards of the pharmaceutical industry.

- The Kingdom has shown seriousness in dealing with the epidemiological situation of the "Covid-19" pandemic since its emergence, as it became one of the first countries to approve the "Pfizer-BioNTech" vaccine, and the vaccination process begins, indicating the approval of other vaccines after testing them soon.

- The number of those wishing and desiring to receive the Corona virus vaccine in the Kingdom increased, especially after its arrival in the country, where more than 700,000 people applied to obtain the vaccine, and the Saudi Deputy Defense Minister Prince Khalid bin Salman bin Abdulaziz received yesterday On Sunday, the first dose of the vaccine, while the Saudi Crown Prince, Prince Mohammed bin Salman, received it earlier.

- On Tuesday, the advisor to the Custodian of the Two Holy Mosques, Prince Khaled Al-Faisal, the Governor of Makkah Al-Mukarramah region, received the first dose at the first vaccine center in Jeddah, as part of the national plan implemented by the Ministry of Health. Recommend : Most notable side effects that may appear after taking Coronavirus vaccine